The collection of essays by Shepley and other authors is intended for students, academics and practitioners in all design fields to inspire societal contribution and celebrate collaboration.
Researchers have uncovered DNA markers associated with retroelements, remnants of ancient viral genetic material, in our genes that act as highly accurate epigenetic clocks predicting chronological age.
An iron-binding drug that is already approved for treatment of other diseases could provide a novel way to attack ovarian tumors, according to a new study led by Weill Cornell Medicine researchers.
Marion Nestle, a food policy expert and public health advocate, will share her experience bridging research, policy and public engagement in a talk, “Food Politics: An Agenda for 2024.”
The College of Veterinary Medicine will welcome an embedded counselor to its halls in early November, piloting a new element as part of campus-wide efforts to enhance mental health support.
A decline in estrogen during menopause causes changes in body fat distribution and associated cardiovascular and metabolic disease, but a new Cornell-led study identifies potential therapies that might one day reverse these unhealthy shifts.
A new preclinical model offers a unique platform for studying the Parkinson’s disease process and suggests a relatively easy method for detecting the disease.
Male breast cancer has distinct alterations in the tumor genome that may suggest potential treatment targets, according to a study by Weill Cornell Medicine investigators.
On Sept. 11 and 12, nearly 100 researchers from the Ithaca Campus and the Weill Cornell Medicine Campus in New York City came together for the symposium, Metabolic Health: From Molecules to Populations.